AADI BIOSCIENCE, INC. : Results of Operations and Financial

Item 2.02. Results of Operations and Financial Condition.

On November 9, 2022, Aadi Bioscience, Inc. issued a press
release announcing its financial results for the fiscal quarter ended
September... | November 9, 2022

Related Keywords

Brendan Delaney , Neil Desai , Board The Compensation Committee , Company The Delaney , Celgene Corporation , Company The Board , Compensation Committee , Nasdaq , Aadi Bioscience Inc , Rutgers University , York University , Stern School Of Business , Beyondspring Pharmaceuticals Inc , Constellation Pharmaceuticals Inc , Immunomedics Inc , Securities Exchange , Company Common Stock , Bristol Myers Squibb Company , Securities Exchange Act , Securities Act , Exchange Act , Certain Officers , Compensatory Arrangements , Chief Executive Officer , Executive Chairman , Chief Operating Officer , Board Size , Board Effective , Restated Executive Employment Agreement , Delaney Employment Agreement , Incentive Plan , Delaney Option , Common Stock , Nasdaq Capital Market , Effective Date , Control Period , Good Reason , Consolidated Omnibus Budget Reconciliation Act , Delaney Release , Chief Commercial Officer , Vice President , Global Marketing , Executive Director , Multiple Myeloma , Global Chronic Myeloid Leukemia , Novartis Oncology , Renal Cell , Spring Pharmaceuticals , Stern School , Securities Purchase Agreement , Regulations K , Current Report , Desai Employment Agreement , Desai Option , Exhibit Number , Page Interactive Data File , Edgar Online , Aadi Bioscience , Nc Stock Exchange , News , Information , Press Release , Item , Results , F , Operations , End , Financial , November , Wadi , Ssued , Nnouncing , Its , Or , The , Iscal , Uarter Aadi Us00032q1040 ,